Risdiplam
ATC M09AX10 · 10 markets · 22 records
AU 5 records · 4 strengths
- 5 mgtabletEVRYSDIEVRYSDI risdiplam 5 mg tablet blister pack
- 0.75 mg/1 mLpowderEVRYSDI
- 0.75 mg/mLpowderEVRYSDI risdiplam 0.75 mg/mL powder for oral solution bottle
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 3 records · 2 strengths
- 5 mgtabletEVRYSDI
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 2 records · 2 strengths
CA 2 records · 2 strengths
SG 2 records · 2 strengths
- 5 mgtabletEVRYSDI
- 60 mgpowderEVRYSDI Powder for Oral Solution 0.75 mg/mL
ES 2 records · 2 strengths
TW 2 records · 2 strengths
- 5 mgtabletEVRYSDI服脊立膜衣錠5毫克
- 0.75 mgpowderEVRYSDI Powder for Oral Solution 0.75 mg/mL服脊立口服溶液用粉劑0.75毫克/毫升
HK 2 records · 1 strengths
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 0.75 mg/1 mLpowderEVRYSDI 0,75 mg/mL, poudre pour solution buvable
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 mg tablet | EVRYSDI | EVRYSDI | EVRYSDI | EVRYSDI EVRYSDI risdiplam 5 mg tablet blister pack | EVRYSDI | EVRYSDI | EVRYSDI 服脊立膜衣錠5毫克 | |||
| 0.75 mg powder | EVRYSDI | EVRYSDI | EVRYSDI Powder for Oral Solution 0.75 mg/mL 服脊立口服溶液用粉劑0.75毫克/毫升 | |||||||
| 0.75 mg/1 mLRecorded as: 750 microgram/1 mL powder | EVRYSDI | EVRYSDI 0,75 mg/mL, poudre pour solution buvable | ||||||||
| 0.75 mg/1 mL liquid | EVRYSDI | |||||||||
| 60 mg powder | EVRYSDI Powder for Oral Solution 0.75 mg/mL | |||||||||
| 0.75 mg/mL powder | EVRYSDI risdiplam 0.75 mg/mL powder for oral solution bottle | |||||||||
unknown | EVRYSDI | EVRYSDI EVRYSDI Powder for Oral Solution 0.75 mg/mL | EVRYSDI | |||||||
liquid | Evrysdi 0.75mg/ml oral solution |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in GB · SG · ES and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en GB · SG · ES que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 GB · SG · ES 有记录(未在本表显示)。 另有 3 個規格/劑型僅在 GB · SG · ES 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.